Company

Rehabwheel Inc., established in 2024, is a U.S.-based medical device company focused on the development, manufacturing, servicing, and distribution of physiotherapy solutions for individuals affected by stroke, musculoskeletal disorders, spinal cord injuries, Alzheimer’s disease, paraplegia, and tetraplegia.

Rehabwheel operates at the intersection of medical devices, physiotherapy, and applied artificial intelligence, with a mission to make effective rehabilitation accessible beyond traditional clinical settings. The company holds U.S. Patent No. 10,603,541, titled “Simulator system and method for exercising lower limbs of a user seated on a wheelchair or like vehicular system.”

LegMaker, Rehabwheel’s flagship technology, is a patented U.S. and China system designed to enable structured lower-limb exercise for wheelchair users, supporting circulation, mobility, and long-term physical health.

Rehabwheel integrates AI-enabled analytics and software intelligence to support personalized therapy parameters, usage monitoring, and outcome tracking, enabling scalable deployment across home, clinical, and institutional environments.

The company’s mission is to deliver high-quality, low-cost physiotherapy solutions globally. In the United States alone, more than 5 million people live with paralysis or significant lower-extremity mobility impairment, highlighting the need for accessible, technology-driven rehabilitation solutions.